DIA415.36+6.58 1.61%
SPX5,638.94+117.42 2.13%
IXIC17,754.09+451.07 2.61%

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga·01/17/2025 12:05:43
Listen to the news

Gainers

  • iSpecimen (NASDAQ:ISPC) stock rose 33.3% to $3.8 during Friday's pre-market session. The company's market cap stands at $3.6 million.
  • NAYA Biosciences (NASDAQ:NAYA) stock rose 22.02% to $0.51. The company's market cap stands at $2.5 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares increased by 14.28% to $2.0. The market value of their outstanding shares is at $4.1 million.
  • Vincerx Pharma (NASDAQ:VINC) stock increased by 11.13% to $0.16. The company's market cap stands at $5.6 million.
  • VSee Health (NASDAQ:VSEE) stock rose 9.92% to $1.55. The market value of their outstanding shares is at $24.2 million.
  • OnKure Therapeutics (NASDAQ:OKUR) stock increased by 9.81% to $6.6. The market value of their outstanding shares is at $88.0 million.

Losers

  • Champions Oncology (NASDAQ:CSBR) stock decreased by 12.5% to $8.71 during Friday's pre-market session. The company's market cap stands at $119.3 million.
  • QT Imaging Holdings (NASDAQ:QTI) shares declined by 10.23% to $0.47. The market value of their outstanding shares is at $10.3 million.
  • Oragenics (AMEX:OGEN) shares declined by 9.4% to $0.27. The market value of their outstanding shares is at $3.3 million.
  • Know Labs (AMEX:KNW) shares decreased by 8.79% to $0.13. The company's market cap stands at $13.7 million.
  • Venus Concept (NASDAQ:VERO) shares decreased by 8.11% to $0.34. The market value of their outstanding shares is at $2.4 million.
  • Zhengye Biotechnology (NASDAQ:ZYBT) stock declined by 7.68% to $4.33. The company's market cap stands at $204.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.